NCT04056962View on ClinicalTrials.gov

Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

August 30, 2024

Study Completion Date

October 28, 2024

Conditions

Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma

Interventions

DRUG

Tacrolimus ointment

topical application of tacrolimus at different concentrations for treatment of superficial Kaposiform hemangioendothelioma (KHE) and tufted angioma (TA).

Trial Locations (1)

610041

RECRUITING

West China Hospital of Sichuan University, Chengdu

All Listed Sponsors

lead

West China Hospital

OTHER